Page 1 Back to LEO

AbbVie

Devoted to new discoveries

This challenge is currently inactive.
Please see our Networks page to discover other Networks your innovation/expertise could be applicable to.

Seeking solutions in novel targets/assets in the wnt/beta-catenin signalling pathway for Oncology, & identifying novel targets from proteostasis networks that implicate neurodegenerative indications.

Network Summary

Background 

Research and innovation are the cornerstones of AbbVie. They advance leading-edge science through a dynamic and collaborative approach. This enables them to find better solutions for treating the world's most challenging diseases. AbbVie focus on discovering, developing and delivering drugs in therapeutic areas where we have proven expertise - and can make an impact.

Challenges

AbbVie are currently seeking solutions in the following areas and solutions can be at any stage of development:

1. Novel targets/assets in the wnt/beta-catenin signalling pathway for Oncology indications.

2. Identifying novel targets from proteostasis networks that have implications for neurodegenerative indications - with a focus on the following three indications: Alzheimer's Disease, Parkinson's Disease and Multiple Sclerosis.

If you have or are developing solutions, or if you have expertise in the above, please click "Apply" to submit your solution/expertise to the Network.

Apply

;